FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corporation today announced a collaboration with Caliper Life Sciences, Inc. (Nasdaq:CALP) that enables functional cell-based G protein-coupled receptor (GPCR) assays to be performed on Caliper LabChip® platforms. The combined offering bundles the DiscoveRx’s cellular assays (such as PathHunter™ ß Arrestin and cAMP Hunter™) with LabChip systems to help pharmaceutical and biotechnology researchers more efficiently discover GPCR drugs.
